VOYA Investment Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.55M Sell
14,183
-32
-0.2% -$7.96K ﹤0.01% 969
2025
Q4
$3.91M Sell
14,215
-2,160
-13% -$591K ﹤0.01% 959
2025
Q3
$4.3M Sell
16,375
-3,523
-18% -$856K ﹤0.01% 923
2025
Q2
$4.35M Sell
19,898
-14,271
-42% -$3.05M ﹤0.01% 1008
2025
Q1
$7.65M Sell
34,169
-809
-2% -$223K 0.01% 813
2024
Q4
$11.5M Sell
34,978
-2,255
-6% -$710K 0.01% 711
2024
Q3
$11.2M Sell
37,233
-2,563
-6% -$785K 0.01% 730
2024
Q2
$13.1M Sell
39,796
-6,184
-13% -$2.19M 0.01% 679
2024
Q1
$18.2M Sell
45,980
-1,953
-4% -$722K 0.02% 572
2023
Q4
$16.9M Sell
47,933
-1,444
-3% -$511K 0.02% 571
2023
Q3
$18.5M Sell
49,377
-1,691
-3% -$654K 0.02% 522
2023
Q2
$19.5M Buy
51,068
+4,421
+9% +$1.58M 0.02% 527
2023
Q1
$16.2M Sell
46,647
-711
-2% -$208K 0.02% 586
2022
Q4
$11.1M Buy
47,358
+125
+0.3% +$29.6K 0.01% 691
2022
Q3
$11.6M Sell
47,233
-792
-2% -$241K 0.01% 655
2022
Q2
$14.5M Sell
48,025
-5,420
-10% -$1.76M 0.04% 399
2022
Q1
$22M Sell
53,445
-1,145
-2% -$448K 0.05% 332
2021
Q4
$25.6M Buy
54,590
+13,056
+31% +$5.62M 0.05% 309
2021
Q3
$17.6M Sell
41,534
-880
-2% -$371K 0.04% 374
2021
Q2
$15.2M Sell
42,414
-5,519
-12% -$1.82M 0.03% 446
2021
Q1
$13.5M Sell
47,933
-1,996
-4% -$571K 0.03% 469
2020
Q4
$14.1M Sell
49,929
-3,269
-6% -$917K 0.03% 449
2020
Q3
$14.6M Sell
53,198
-1,829
-3% -$484K 0.03% 410
2020
Q2
$12.5M Buy
55,027
+17,228
+46% +$3.38M 0.03% 450
2020
Q1
$5.75M Buy
37,799
+3,953
+12% +$608K 0.02% 654
2019
Q4
$5.09M Buy
33,846
+5,756
+20% +$838K 0.01% 797
2019
Q3
$3.98M Buy
28,090
+680
+2% +$93.6K 0.01% 854
2019
Q2
$3.43M Buy
27,410
+2,277
+9% +$269K 0.01% 902
2019
Q1
$2.77M Buy
25,133
+2,002
+9% +$208K 0.01% 956
2018
Q4
$2.27M Buy
23,131
+6,357
+38% +$690K 0.01% 966
2018
Q3
$2.07M Sell
16,774
-384
-2% -$43.1K ﹤0.01% 1080
2018
Q2
$1.7M Sell
17,158
-9,396
-35% -$865K ﹤0.01% 1122
2018
Q1
$2.34M Sell
26,554
-275
-1% -$25.7K 0.01% 1001
2017
Q4
$2.65M Sell
26,829
-1,098
-4% -$108K 0.01% 978
2017
Q3
$2.69M Sell
27,927
-308
-1% -$27.9K 0.01% 953
2017
Q2
$2.67M Sell
28,235
-596
-2% -$54.8K 0.01% 956
2017
Q1
$2.35M Sell
28,831
-1,183
-4% -$98.9K 0.01% 993
2016
Q4
$2.55M Sell
30,014
-2,004
-6% -$158K 0.01% 964
2016
Q3
$2.38K Buy
32,018
+891
+3% +$70.7K ﹤0.01% 989
2016
Q2
$2.36M Buy
31,127
+987
+3% +$71.8K 0.01% 973
2016
Q1
$2.09M Hold
30,140
0.01% 990
2015
Q4
$1.81M Hold
30,140
﹤0.01% 1026
2015
Q3
$1.63M Sell
30,140
-15,110
-33% -$881K ﹤0.01% 1079
2015
Q2
$2.63M Sell
45,250
-3,415
-7% -$191K 0.01% 969
2015
Q1
$2.93M Sell
48,665
-1,653
-3% -$88.1K 0.01% 955
2014
Q4
$2.68M Sell
50,318
-2,540
-5% -$127K 0.01% 989
2014
Q3
$2.37M Sell
52,858
-1,441
-3% -$61.2K 0.01% 1020
2014
Q2
$2.29M Buy
54,299
+250
+0.5% +$10.7K 0.01% 1048
2014
Q1
$2.38M Hold
54,049
0.01% 1047
2013
Q4
$2.65M Buy
54,049
+3,951
+8% +$185K 0.01% 986
2013
Q3
$2.06M Hold
50,098
0.01% 1077
2013
Q2
$1.76M Buy
+50,098
New +$1.65M ﹤0.01% 1115

Other funds holding WST

VOYA Investment Management's WST Position: Q1 2026 in Review

VOYA Investment Management reduced its West Pharmaceutical (WST) stake by 0.23% in Q1 2026, selling an estimated $7.96K and leaving 14,183 shares worth $3.55M. The position accounts for ﹤0.01% of the portfolio, ranked #969.

VOYA Investment Management first reported a position in WST in Q2 2013 and has held it in 52 quarters since. The position peaked at $25.6M in Q4 2021. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • VOYA Investment Management held 14,183 shares of West Pharmaceutical worth $3.55M as of Q1 2026.
  • VOYA Investment Management sold 32 West Pharmaceutical shares in Q1 2026, an estimated $7.96K.
  • West Pharmaceutical made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #969 holding.
  • VOYA Investment Management first reported a position in West Pharmaceutical in Q2 2013 and has held it in 52 quarters since.
  • VOYA Investment Management's West Pharmaceutical position peaked at $25.6M in Q4 2021.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.